November 8, 2021 – Medtronic plc (Dublin, Ireland) announced its ambition to achieve net zero carbon emissions by fiscal year (FY) 2045 across its operations and value chain (scopes 1, 2, and 3) to accelerate efforts to combat climate change.
As published in Medtronic’s new Decarbonization Roadmap, the FY45 milestone builds on the company’s existing goal of reaching carbon neutrality in its operations by FY30, to encompass GHG emissions reductions across its entire value chain.
To achieve its ambition, Medtronic will pursue setting GHG emission reduction targets across scopes 1, 2, and 3 through the Science-Based Targets Initiative (SBTi) – a multi-year initiative that provides companies a clearly defined path to reduce emissions aligned with the Paris Agreement.
Medtronic’s new aspiration to reach net zero emissions by FY45 is part of the company’s ongoing environmental, social and governance (ESG) strategy.